SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: axial who wrote (13758)10/24/2004 3:55:04 PM
From: Cal Gary  Read Replies (1) of 14101
 
Dimethaid announces revamped Pennsaid pact


By Leonard Zehr
Saturday, October 23, 2004 - Page B10

Drug maker Dimethaid Research Inc. has renegotiated a sales and marketing agreement with Solvay Pharma Inc. for the distribution of its osteoarthritis lotion Pennsaid. Under the new accord, Markham, Ont.-based Dimethaid will no longer distribute Pennsaid and all promotion will be handled by Solvay. In mid-September, Solvay advised Dimethaid that it intended to end distributing Pennsaid, citing "alleged contractual breaches." The new distribution deal also makes good on a pledge by dissident shareholders who took control of the company at the end of last month. As a result, Dimethaid laid off its sales force of 36 people and several sales managers yesterday. DMX (TSX) rose 2 cents to 69 cents.

theglobeandmail.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext